Patient-Controlled Analgesia Pump Market: Key Inhibitors to Widespread Adoption
The patient-controlled analgesia (PCA) pump market, while holding significant potential for growth, faces several inhibitors that could hinder its widespread adoption and development. These obstacles include high costs, technological limitations, regulatory challenges, and concerns about patient safety and misuse.
One of the primary inhibitors is the high cost of PCA pumps. The initial...
0
0
77
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek